Immuno Oncology Assay Market to Reach USD 18.1 Billion by 2034, Growing at a 12.4% CAGR
Rising cancer prevalence and advancements in diagnostics drive the immuno-oncology assay market, with breakthroughs in NGS, PCR, & immunoassays leading growth. NEWARK, DE, UNITED STATES, December 16, 2024 /EINPresswire.com/ -- The global …